Expand CHRS Menu
CHRS MENU

Coherus Oncology (CHRS)'s 30-day implied volatility (IV30) was 137.9% at the close on October 27, 2026, down from 180.0% the day before, against a 52-week range of 51.5% to 180.0%. Its 20-day historical volatility was 67.4%.

Key numbers
  • 30-day implied volatility (IV30): 137.9%
  • IV30 52-week range: 51.5% to 180.0% (median 81.2%)
  • Historical volatility: 20-day 67.4%, 1-year 78.7%
  • Implied move by the nearest expiration: ±12.1%

Data as of October 27, 2026.

CHRS Implied Volatility (IV) vs Historical Volatility (HV)

Market Data Delayed 15 Minutes